Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Neuropharmacology. 2015 Aug 13;99:491–499. doi: 10.1016/j.neuropharm.2015.08.017

Figure 2. Effects of dopamine receptor antagonists on Y416 phosphorylation in the rat striatum and mPFC.

Figure 2

(A) Effects of SCH23390 and eticlopride on Y416 phosphorylation and Src and Fyn expression in the striatum. (B) Effects of SCH23390 and eticlopride on Y416 phosphorylation and Src and Fyn expression in the mPFC. Representative immunoblots are shown left to the quantified data. Rats were given a single dose of SCH23390 (0.1-0.5 mg/kg, i.p.) or eticlopride (0.5 mg/kg, i.p.) and sacrificed 20 min after drug injection for immunoblot analysis. Data are presented as means ± SEM (n = 4 per group). *P < .05 versus saline (one-way ANOVA).